These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


68 related items for PubMed ID: 1084525

  • 1. Plasma natriuretic activity in oedematous states.
    Kramer HJ, Krück F.
    Proc Eur Dial Transplant Assoc; 1976; 12():321-9. PubMed ID: 1084525
    [Abstract] [Full Text] [Related]

  • 2. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 3. Third factor and edema formation.
    Krück F, Kramer HJ.
    Contrib Nephrol; 1978 Apr; 13():12-20. PubMed ID: 309381
    [Abstract] [Full Text] [Related]

  • 4. The presence of a natriuretic factor in urine of patients with chronic uremia. The absence of the factor in nephrotic uremic patients.
    Bourgoignie JJ, Hwang KH, Ipakchi E, Bricker NS.
    J Clin Invest; 1974 Jun; 53(6):1559-67. PubMed ID: 4830222
    [Abstract] [Full Text] [Related]

  • 5. [Atrial natriuretic peptide in children with nephrotic syndrome].
    Jovanovitsh O, Popovitsh-Rolovitsh M, Radoshevitsh P, Stankovitsh R, Dujitsh A, Gajitsh M, Peco-Antitsh A, Krushchitsh D, Kostitsh M.
    Srp Arh Celok Lek; 1995 Jun; 123(11-12):291-4. PubMed ID: 16296241
    [Abstract] [Full Text] [Related]

  • 6. Dependence of saline-induced natriuresis upon exposure of the kidney to the physical effects of extracellular fluid volume expansion.
    Fitzgibbons JP, Gennari FJ, Garfinkel HB, Cortell S.
    J Clin Invest; 1974 Dec; 54(6):1428-36. PubMed ID: 4436441
    [Abstract] [Full Text] [Related]

  • 7. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM.
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of uroguanylin on natriuresis in experimental nephrotic rats.
    Baba A, Fujimoto S, Kikuchi M, Kita T, Kitamura K.
    Nephrology (Carlton); 2009 Feb; 14(1):80-5. PubMed ID: 19054333
    [Abstract] [Full Text] [Related]

  • 10. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE, Sørensen AM, Petersen JS, Andreasen F, Christensen S.
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [Abstract] [Full Text] [Related]

  • 11. Renal interstitial hydrostatic pressure and sodium excretion in hypertension and pregnancy.
    Khraibi AA.
    J Hypertens Suppl; 2002 Jun; 20(3):S21-7. PubMed ID: 12187911
    [Abstract] [Full Text] [Related]

  • 12. Sodium retention in chronic liver disease: lack of a natriuretic factor?
    Naccarato R, D'Angelo A, Chiaramonte M, Messa P, Gregolin C, Zanon GF.
    Biomedicine; 1978 Apr; 29(2):47. PubMed ID: 566589
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of edema formation in the nephrotic syndrome.
    Palmer BF, Alpern RJ.
    Kidney Int Suppl; 1997 Jun; 59():S21-7. PubMed ID: 9185099
    [Abstract] [Full Text] [Related]

  • 14. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
    Sampaio-Maia B, Moreira-Rodrigues M, Serrão P, Pestana M.
    Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
    [Abstract] [Full Text] [Related]

  • 15. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide.
    Trevisani F, Colantoni A, Sica G, Gasbarrini A, D'Intino PE, De Notariis S, De Jaso R, Barbieri A, Morselli A, Gasbarrini G.
    Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 17. Renal handling of sodium and water in early chronic liver disease. Evidence for a reduced natriuretic activity of the cirrhotic urinary extracts in rats.
    Naccarato R, Messa P, D'Angelo A, Fabris A, Messa M, Chiaramonte M, Gregolin C, Zanon G.
    Gastroenterology; 1981 Aug; 81(2):205-10. PubMed ID: 7239129
    [Abstract] [Full Text] [Related]

  • 18. The evidence of production or activation of a natriuretic factor in the liver.
    Ivanov YI.
    Endocrinol Exp; 1979 Aug; 13(4):195-200. PubMed ID: 316383
    [Abstract] [Full Text] [Related]

  • 19. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis.
    Burghardt W, Wernze H, Diehl KL.
    Klin Wochenschr; 1986 Aug; 64 Suppl 6():103-7. PubMed ID: 2948055
    [Abstract] [Full Text] [Related]

  • 20. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
    Levy M.
    Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.